Table 2.
Condition | Day 0 | Day 1 | Day 7 | Day 14 | Day 28 |
CT none | 179.74 ± 4.02 | 182.28 ± 4.15 | 242.78 ± 6.18 | 304.06 ± 13.26 | 391.34 ± 9.80 |
CT + AV | 167.17 ± 4.38 | 172.97 ± 4.53 | 234.77 ± 5.27 | 287.67 ± 4.67 | 404.10 ± 12.46 |
CT + SV | 181.89 ± 8.26 | 184.19 ± 8.12 | 248.40 ± 7.99 | 291.69 ± 6.93 | 394.14 ± 15.92 |
CT + PV | 193.81 ± 8.25 | 198.85 ± 7.66 | 262.99 ± 9.03 | 301.19 ± 8.02 | 389.64 ± 11.48 |
Diabetic none | 180.22 ± 5.99 | 172.53 ± 5.24 | 198.19 ± 7.41 | 211.94 ± 11.11a | 267.10 ± 27.98a |
Diabetic + AV | 176.30 ± 3.10 | 159.86 ± 9.93 | 202.32 ± 5.13 | 235.45 ± 8.56a | 255.40 ± 17.09a |
Diabetic + SV | 183.14 ± 4.68 | 178.24 ± 4.29 | 207.69 ± 6.81 | 230.13 ± 7.23a | 241.65 ± 12.73a |
Diabetic + PV | 187.88 ± 5.62 | 182.58 ± 4.60 | 204.85 ± 7.18 | 243.69 ± 5.60a | 253.99 ± 11.82a |
P < 0.05 vs age-matched C. Values are means ± SEM. Rats were injected with STZ on day 0. Blood glucose for diabetic rats: n = average of 10 rats per group. STZ: Streptozotocin; AV: Atorvastatin; SV: Simvastatin; PV: Pravastatin; CT: Control.